Cargando…
Prognostic impact of Clinical Frailty Scale in patients with heart failure with preserved ejection fraction
AIMS: Frailty is associated with prognosis of cardiovascular diseases. However, the significance of frailty in patients with heart failure with preserved ejection fraction (HFpEF) remains to be elucidated. The purpose of this study was to examine the prognostic significance of the Clinical Frailty S...
Autores principales: | Sunaga, Akihiro, Hikoso, Shungo, Yamada, Takahisa, Yasumura, Yoshio, Uematsu, Masaaki, Tamaki, Shunsuke, Abe, Haruhiko, Nakagawa, Yusuke, Higuchi, Yoshiharu, Fuji, Hisakazu, Mano, Toshiaki, Kurakami, Hiroyuki, Yamada, Tomomi, Kitamura, Tetsuhisa, Sato, Taiki, Oeun, Bolrathanak, Kida, Hirota, Kojima, Takayuki, Sotomi, Yohei, Dohi, Tomoharu, Okada, Katsuki, Suna, Shinichiro, Mizuno, Hiroya, Nakatani, Daisaku, Sakata, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318468/ https://www.ncbi.nlm.nih.gov/pubmed/34151546 http://dx.doi.org/10.1002/ehf2.13482 |
Ejemplares similares
-
Factors Associated With Elevated N-Terminal Pro B-Type Natriuretic Peptide Concentrations at the Convalescent Stage and 1-Year Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
por: Oeun, Bolrathanak, et al.
Publicado: (2020) -
P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials
por: Sotomi, Yohei, et al.
Publicado: (2023) -
Relationships of Atrial Fibrillation at Diagnosis and Type of Atrial Fibrillation During Follow-up With Long-Term Outcomes for Heart Failure With Preserved Ejection Fraction
por: Nakatani, Daisaku, et al.
Publicado: (2022) -
Prognostic significance of dipstick proteinuria in heart failure with preserved ejection fraction: insight from the PURSUIT-HFpEF registry
por: Oeun, Bolrathanak, et al.
Publicado: (2021) -
Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
por: Sunaga, Akihiro, et al.
Publicado: (2022)